10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2013 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 24, 2014) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
| Revenues: | |||
| Product sales | $ 18,192 | 16,639 | 15,295 |
| Other revenues | 484 | 626 | 287 |
| Total revenues | 18,676 | 17,265 | 15,582 |
| Operating expenses: | |||
| Cost of sales | 3,346 | 3,199 | 2,708 |
| Research and development | 4,083 | 3,380 | 3,167 |
| Selling, general and administrative | 5,184 | 4,814 | 4,499 |
| Other | 196 | 295 | 896 |
| Total operating expenses | 12,809 | 11,688 | 11,270 |
| Operating income | 5,867 | 5,577 | 4,312 |
| Interest expense, net | 1,022 | 1,053 | 610 |
| Interest and other income, net | 420 | 485 | 448 |
| Income before income taxes | 5,265 | 5,009 | 4,150 |
| Provision for income taxes | 184 | 664 | 467 |
| Net income | 5,081 | 4,345 | 3,683 |
| Earnings per share: | |||
| Basic (in usd per share) | 6.75 | 5.61 | 4.07 |
| Diluted (in usd per share) | 6.64 | 5.52 | 4.04 |
| Shares used in the calculation of earnings per share: | |||
| Basic (in shares) | 753 | 775 | 905 |
| Diluted (in shares) | 765 | 787 | 912 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2013 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 24, 2014) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
| Net income | $ 5,081 | 4,345 | 3,683 |
| Other comprehensive income (loss), net of reclassification adjustments and taxes: | |||
| Foreign currency translation losses | (80) | (9) | (1) |
| Effective portion of cash flow hedges | 2 | (78) | 40 |
| Net unrealized gains (losses) on available-for-sale securities | (226) | 63 | (15) |
| Other | (3) | (1) | (6) |
| Other comprehensive income (loss), net of tax | (307) | (25) | 18 |
| Comprehensive income | 4,774 | 4,320 | 3,701 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2013 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 24, 2014) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
| Cash flows from operating activities: | |||
| Net income | $ 5,081 | 4,345 | 3,683 |
| Depreciation and amortization | 1,286 | 1,088 | 1,060 |
| Stock-based compensation expense | 403 | 362 | 341 |
| Deferred income taxes | (189) | 28 | (328) |
| Property, plant and equipment impairments | 19 | 178 | 6 |
| Other items, net | 84 | (74) | 63 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (38) | 348 | (557) |
| Inventories | (7) | (150) | (383) |
| Other assets | (59) | 124 | (204) |
| Accounts payable | (184) | 161 | (95) |
| Accrued income taxes | (326) | 87 | (20) |
| Legal reserve | 0 | (780) | 780 |
| Other liabilities | 221 | 165 | 773 |
| Net cash provided by operating activities | 6,291 | 5,882 | 5,119 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (693) | (689) | (567) |
| Cash paid for acquisitions, net of cash acquired | (9,434) | (2,390) | (701) |
| Purchases of marketable securities | (21,965) | (26,241) | (21,183) |
| Proceeds from sales of marketable securities | 19,123 | 17,372 | 20,871 |
| Proceeds from maturities of marketable securities | 5,090 | 1,994 | 749 |
| Change in restricted investments, net | (520) | 0 | 0 |
| Other | (70) | (36) | 45 |
| Net cash used in investing activities | (8,469) | (9,990) | (786) |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 8,054 | 4,933 | 10,387 |
| Repayment of debt | (3,371) | (123) | (2,500) |
| Net proceeds from issuance of commercial paper | 0 | 0 | 762 |
| Repayments of commercial paper | 0 | 0 | (762) |
| Repurchases of common stock | (832) | (4,607) | (8,315) |
| Dividends paid | (1,415) | (1,118) | (500) |
| Net proceeds from issuance of common stock in connection with the Company's equity award programs | 296 | 1,288 | 242 |
| Other | (6) | 46 | 12 |
| Net cash provided by (used in) financing activities | 2,726 | 419 | (674) |
| Increase (decrease) in cash and cash equivalents | 548 | (3,689) | 3,659 |
| Cash and cash equivalents at beginning of period | 3,257 | 6,946 | |
| Cash and cash equivalents at end of period | 3,805 | 3,257 | 6,946 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2013 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2013 10-K (Filed: Feb 24, 2014) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2013 | Dec 31, 2012 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 3,805 | 3,257 |
| Marketable securities | 15,596 | 20,804 |
| Trade receivables, net | 2,697 | 2,518 |
| Inventories | 3,019 | 2,744 |
| Other current assets | 2,250 | 1,886 |
| Total current assets | 27,367 | 31,209 |
| Property, plant and equipment, net | 5,349 | 5,326 |
| Intangible assets, net | 13,262 | 3,968 |
| Goodwill | 14,968 | 12,662 |
| Restricted investments | 3,412 | 0 |
| Other assets | 1,767 | 1,133 |
| Total assets | 66,125 | 54,298 |
| LIABILITIES AND STOCKHOLDERS EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 787 | 905 |
| Accrued liabilities | 4,655 | 4,791 |
| Current portion of long-term debt | 2,505 | 2,495 |
| Total current liabilities | 7,947 | 8,191 |
| Long-term debt | 29,623 | 24,034 |
| Other noncurrent liabilities | 6,459 | 3,013 |
| Contingencies and commitments | ||
| Stockholders equity: | ||
| Common stock and additional paid-in capital; $0.0001 par value; 2,750.0 shares authorized; outstanding 754.6 shares in 2013 and 756.3 shares in 2012 | 29,891 | 29,337 |
| Accumulated deficit | (7,634) | (10,423) |
| Accumulated other comprehensive income (loss) | (161) | 146 |
| Total stockholders equity | 22,096 | 19,060 |
| Total liabilities and stockholders equity | 66,125 | 54,298 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2013 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |